DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Exelixis, Inc. (EXEL)
« Back to company indexEXEL Chatter Timeline
Stock Ticker for EXEL
Most Active Tweeters for EXEL
| User | Tweets |
|---|---|
| @dailypoliticaln | 4 |
| @ConsumerFeed | 4 |
| @TickerReport | 3 |
| @AmericanBanking | 3 |
| @reurope_stock | 3 |
Recent Tweets for EXEL
 |
@Atip4 $exel ..... good stuff https://t.co/mvRqFr2LvG July 19th 2018, 1:07pm |
 |
@SADIFAnalytics Will Exelixis Inc Deliver Long-Term Returns? $EXEL https://t.co/pS5rEWyDuJ July 19th 2018, 7:07am |
 |
@ThisLincolnian Michael Morrissey Sells 90,000 Shares of Exelixis, Inc. $EXEL Stock https://t.co/VVj3wEF1vo July 19th 2018, 4:07am |
 |
@Clover_Research I also have 2 ratings on $EXEL which will eventually come to fruition. People are thinking they'll have another beat come ER. July 18th 2018, 4:07pm |
 |
@PivotBoss [MEMBERS] PivotBoss Trading Room PM [July 18, 2018]: Add $EXEL to the Watchlist https://t.co/1kMRmElr8a #pivotboss July 18th 2018, 4:07pm |
 |
@filing_scanner $EXEL New Insider Filing On: MORRISSEY MICHAEL Transaction Code: M https://t.co/teUYgLfPCI https://t.co/qzE0Merbqa July 18th 2018, 1:07pm |
 |
@pnani456 $EXEL M30 rotation up / D1 50SMA tag and bounce back above 20SMA https://t.co/PaVtadxviV July 18th 2018, 10:07am |
 |
@InsiderAlertsIA $EXEL: New Insider Filing on President and CEO MICHAEL MORRISSEY: https://t.co/ctcFbjAkAv July 18th 2018, 9:07am |
 |
@ConsumerFeed Exelixis, Inc. $EXEL Insider Michael Morrissey Sells 90,000 Shares of Stock https://t.co/kaEDSRnOmR July 18th 2018, 6:07am |
|
@ConsumerFeed Exelixis Insider Michael Morrissey Sells $1,901,700.00 in $EXEL https://t.co/KiGikx2iJH July 18th 2018, 3:07am |
 |
@ataglieri1 Insider alert: President and CEO MORRISSEY MICHAEL of $EXEL bought 90,000 shares @ $495,000.00 July 18th 2018, 2:07am |
|
@filing_scanner $EXEL New Insider Filing On: MORRISSEY MICHAEL Transaction Code: M https://t.co/teUYgLfPCI https://t.co/b0ovt37WDJ July 17th 2018, 11:07pm |
 |
@TickerReport Exelixis, Inc. $EXEL Insider Michael Morrissey Sells 90,000 Shares https://t.co/VSBYm7VIDW July 17th 2018, 10:07pm |
 |
@AmericanBanking Exelixis, Inc. $EXEL Insider Michael Morrissey Sells 90,000 Shares https://t.co/QS0qslL2g2 #stocks July 17th 2018, 10:07pm |
 |
@dailypoliticaln Exelixis, Inc. $EXEL Insider Sells $1,901,700.00 in Stock https://t.co/8bgEJWcOcL July 17th 2018, 10:07pm |
 |
@insiderbuyings $EXEL new insider selling: 90000 shares. https://t.co/xjRrt8STVo July 17th 2018, 9:07pm |
 |
@StockTexts $EXEL Exelixis, Inc. SEC Filing: Form 4 https://t.co/WZSZgO85J3 July 17th 2018, 8:07pm |
 |
@poor_pinkus $EXEL investors: We’ll be announcing our Q2 earnings on 8/1. Webcast details here: https://t.co/8fGb2K9s5x. July 17th 2018, 7:07pm |
|
@poor_pinkus @bibeypost_stock $EXEL I think they come in at $0.22 EPS July 17th 2018, 7:07pm |
 |
@bibeypost_stock Exelixis, Inc. $EXEL Analysts See $0.14 EPS - https://t.co/OaEdLIHHd8 July 17th 2018, 6:07pm |
 |
@reurope_stock $0.14 EPS Expected for Exelixis, Inc. $EXEL https://t.co/KhM3kOjaui July 17th 2018, 6:07pm |
 |
@mmahotstuff1 $0.14 EPS Expected for Exelixis, Inc. $EXEL - https://t.co/v3OF8LWcO7 July 17th 2018, 6:07pm |
 |
@whatsonthorold2 EPS for Exelixis, Inc. $EXEL Expected At $0.14 - https://t.co/GMTOGb3Pns July 17th 2018, 6:07pm |
 |
@ChartMill Although the technical rating is bad, $EXEL does present a nice setup opportunity. https://t.co/eIQbqxkwIy https://t.co/drAIDFyGmM July 17th 2018, 4:07pm |
 |
@ExelixisInc $EXEL investors: We’ll be announcing our Q2 earnings on 8/1. Webcast details here: https://t.co/cwMelmYuQW. https://t.co/I556fR1CmQ July 17th 2018, 4:07pm |
 |
@Allstocknews $EXEL Exelixis to Release Second Quarter 2018 Financial Results on Wednesday, August 1, 2018 From our Stock News Alerts App July 17th 2018, 4:07pm |
|
@AmericanBanking Exelixis, Inc. $EXEL Given Average Rating of “Hold” by Analysts https://t.co/trUJ2Cubn3 #stocks July 17th 2018, 7:07am |
|
@TickerReport Exelixis, Inc. $EXEL Given Average Rating of “Hold” by Analysts https://t.co/J8EexwwpG9 July 17th 2018, 7:07am |
|
@dailypoliticaln Exelixis, Inc. $EXEL Given Consensus Rating of “Hold” by Brokerages https://t.co/ewqwuK4ex3 July 17th 2018, 7:07am |
 |
@studentoflife RT @tgtxdough: RBC $EXEL looking specifically for guidance updates for Cabometyx (Cabo) given the approval of IO combo Opdivo + Yervoy in 1… July 16th 2018, 1:07pm |
 |
@tgtxdough RBC $EXEL looking specifically for guidance updates for Cabometyx (Cabo) given the approval of IO combo Opdivo + Ye… https://t.co/h0gVG2IPnd July 16th 2018, 12:07pm |
|
@bibeypost_stock Were Analysts Bearish Exelixis, Inc. $EXEL This Week? - https://t.co/0XFZOMTQgE July 15th 2018, 10:07am |
|
@reurope_stock How Many Exelixis, Inc. $EXEL's Analysts Are Bullish? https://t.co/02rY3WfNsm July 15th 2018, 10:07am |
 |
@MareaInformativ Exelixis, Inc. $EXEL Short Interest Update https://t.co/q9z1fZrqlc July 15th 2018, 6:07am |
|
@dailypoliticaln Exelixis, Inc. $EXEL Short Interest Update https://t.co/yrEgLc7bwn July 15th 2018, 1:07am |
|
@ThisLincolnian Short Interest in Exelixis, Inc. $EXEL Increases By 39.2% https://t.co/EezgxITdfv July 14th 2018, 8:07pm |
|
@ConsumerFeed Short Interest in Exelixis, Inc. $EXEL Increases By 39.2% https://t.co/7VTdboXUyF July 14th 2018, 8:07pm |
 |
@ResearchPool $EXEL #Exelixis Inc. Cabozantinib is approved in three indications but needs further entrenchment to dig a moat.: S… https://t.co/NhvOXTysep July 13th 2018, 3:07pm |
|
@AmericanBanking Exelixis, Inc. $EXEL Short Interest Up 39.2% in June https://t.co/iLPiQ8Bq91 #stocks July 13th 2018, 2:07am |
 |
@TranscriptDaily Exelixis, Inc. $EXEL Short Interest Up 39.2% in June https://t.co/URaneOluu9 July 13th 2018, 2:07am |
 |
@TraderJoost https://t.co/sq4xVuBRcM Long $Exel through options 21 and 22 strike various exps. July 12th 2018, 10:07am |
 |
@biogemfinder $EXEL after many months finally an uptrend has started. The 20d moving average is crossing the 50d MA, given all th… https://t.co/XWWWbmGQSc July 11th 2018, 1:07pm |
|
@ChartMill $EXEL has a good Piotroski-F score of 7.00. This indicates a good health and profitability. https://t.co/ARDF3t8ptk https://t.co/MYp2be5uHW July 11th 2018, 11:07am |
 |
@jfais20 $EXEL Piper Jaffray says weakness is a buying opportunity, 92% of surveyed medical oncologists who treat metastatic… https://t.co/6ZLlYaVXsw July 11th 2018, 9:07am |
|
@mmahotstuff1 $0.14 EPS Expected for Exelixis, Inc. $EXEL - https://t.co/KYJFX9PY8Z July 11th 2018, 8:07am |
|
@whatsonthorold2 $0.14 EPS Expected for Exelixis, Inc. $EXEL - https://t.co/VoCWibdzM6 July 11th 2018, 8:07am |
 |
@odibro $EXEL Piper reiterates with an overweight. $29 PT July 11th 2018, 5:07am |
|
@pnani456 $EXEL D1 long setup base breakout play https://t.co/lM5va0JTkc July 10th 2018, 10:07am |
 |
@TheMarketsDaily Exelixis $EXEL versus PRA Health Sciences $PRAH Financial Comparison https://t.co/UspURnaY0Z July 10th 2018, 10:07am |
|
@bibeypost_stock Exelixis Inc $EXEL: Institutional Investors Are Worried - https://t.co/LYNP4ME3Zi July 9th 2018, 6:07am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.